Pulsenmore Ltd.
PLSM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002064764
In the last 90 days, Pulsenmore Ltd. insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.07M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pulsenmore Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $15.7K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$15.7K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pulsenmore Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sonnenschein Elazar | Chief Executive Officer | 892,421Indirect | Nov 5, 2026 | 1 |
| Woods David | Chief Commercial Officer | – | Oct 21, 2026 | 1 |
| Guz-Lavi Racheli | Director | 46,874 | Oct 14, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)4:15 PM ET | Nov 4 | 1 day | Sonnenschein ElazarChief Executive Officer | PPurchase | +9.26K | $1.70 | +$15.7K | +1.0%892.4K after |